Inaugural Lecture - Professor Marie Louise (Marieke) De Bruin – University of Copenhagen

Forward this page to a friend Resize Print kalender-ikon Bookmark and Share

Department of Pharmacy > Calendar > Inaugural Marieke De B...

Inaugural Lecture - Professor Marie Louise (Marieke) De Bruin

The Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, cordially invites you to the inauguration of Marie L. De Bruin as Professor in Regulatory Science.

Professor Marie Louise (Marieke) De Bruin

The inauguration will take place Wednesday November 23th, 2016 from 16:00 in Ceremonial Hall, Frue Plads 4, 1168 Copenhagen.
Following the inauguration seminar there will be a reception in the same building.

Program

16:00-18:00 – Ceremonial Hall, Frue Plads, 1168 Copenhagen

Welcome and inauguration by Professor Sven Frøkjær, on behalf of the Dean of Faculty of Health and Medical Sciences, University of Copenhagen

Inaugural lecture by Marie L. De Bruin: "Science and Regulation, it takes two to tango"

Closure by Flemming Madsen, Head of Department of Pharmacy

18:00
Reception – Ceremonial Hall, Frue Plads, 1168 Copenhagen

Sincerely Yours,
Flemming Madsen Head of Department of Pharmacy

Registration

Everybody is welcome at the lecture and the following reception, and we hope that everyone who knows Marieke De Bruin will come and celebrate her together with us. However, in order to help the planning of the event, we kindly ask you to register by using the online registration form found just below no later than 10 November 2016.

Please register here

Accompanying events

In conjunction to the inauguration, two accompanying events are organised, for which you are invited: the 2nd CORS research seminar (November 23th) and CORS annual conference (November 24th).
For more information please go to CORS Events November 2016

About CORS

The Copenhagen Centre for Regulatory Science (CORS) aims at being the international partner for academic leadership in regulatory science, research and education and to participate in building the regulatory framework that will make innovative medicinal products available to patients.